10-K/A

NABI BIOPHARMACEUTICALS FORM 10-K/A 12-29-2001

Company: Vaxart, Inc.
Filed: April 5, 2002
Period of Report: December 29, 2001
Accession Number: 0000950144-02-003584

View Document ↗ View on SEC.gov ↗